Everybody 12 /Case Studies 0 /Conferences 8 /FreeMind Elite 0 /FreeMind Elite 2024 0 /FreeMind Elite 2025 0 /Job posting 0 /NDFS 2025 Presentations 0 /NDFS 2026 Presentations 0 /News 4 /Opinions 0 /Opportunities 0 /Presentations 0 /Uncategorized 0 /Webinars 0
SBIR/STTR Programs Could Expire September 30. Reauthorization Opposed by Rand Paul.

SBIR/STTR Programs Could Expire Sept. 30

September 14, 2022/by Ayal Ronen

Biden Establishes National Biotechnology and Biomanufacturing Initiative with Executive Order

September 13, 2022/by Ayal Ronen
How Non-Dilutive Funding Can Extend Runway in BioPharma, Biotech, and Tech Bio

Is Non-Dilutive Funding the Key to Extending Runway in Biopharma and Biotech?

September 12, 2022/by Ayal Ronen

BioPharm America, an EBD event, Sept 28-29, Boston (& Virtual)

September 11, 2022/by Ayal Ronen

BioForward, Sept 27, Oxford

September 11, 2022/by Ayal Ronen
Non-dilutive funding leads to equity investment

How Non-Dilutive Funding Leads to Equity Investment: The Story of Enalare

August 29, 2022/by Ayal Ronen
BioFuture, November 7-9, 2022, NYC

Biofuture, a Demy-Colton Event

August 2, 2022/by Ayal Ronen
HealthTech Investment Forum, September 20-22, 2022, in Basel

The HealthTech Investment Forum & Biotech in Europe Forum, Sept. 20-22, Basel

July 20, 2022/by Ayal Ronen

Advanced Therapies Europe, Aug. 31-Sept. 1, London

July 14, 2022/by Ayal Ronen
Redefining Early Stage Funding Conference, Boston, September 21-23

RESI Boston, Sept. 21-23

July 4, 2022/by Ayal Ronen
MEDFIT 2022 Sept 20-21 Grenoble France

MedFIT, Sept. 21-22, Grenoble, France

July 3, 2022/by Ayal Ronen
LSX Nordic September 6-7, 2022, In-Person in Copenhagen

LSX Nordic Congress, Sept. 2022 (Copenhagen)

July 3, 2022/by Ayal Ronen

Recent Posts

Followon XSubscribeto RSS Feed

Reach out to us with your non-dilutive funding requirements